TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ImmunoIVD AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
49,876
|
40,079
|
34,433 |
Financial expenses |
1,710
|
1,495
|
1,297 |
Earnings before taxes |
4,463
|
5,259
|
-2,757 |
EBITDA |
8,129
|
9,058
|
532 |
Total assets |
33,322
|
29,550
|
24,578 |
Current assets |
27,012
|
23,721
|
17,236 |
Current liabilities |
25,147
|
22,824
|
24,445 |
Equity capital |
8,174
|
6,726
|
133 |
- share capital |
101
|
95
|
98 |
Employees (average) |
25
|
23
|
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.5%
|
22.8%
|
0.5% |
Turnover per employee |
1,995
|
1,743
|
1,324 |
Profit as a percentage of turnover |
8.9%
|
13.1%
|
-8.0% |
Return on assets (ROA) |
18.5%
|
22.9%
|
-5.9% |
Current ratio |
107.4%
|
103.9%
|
70.5% |
Return on equity (ROE) |
54.6%
|
78.2%
|
-2072.9% |
Change turnover |
6,952
|
6,681
|
13,111 |
Change turnover % |
16%
|
20%
|
61% |
Chg. No. of employees |
2
|
-3
|
5 |
Chg. No. of employees % |
9%
|
-12%
|
24% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.